SynthesisEuropean journal of medical research2023

Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis.

Lei Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.